Become A Member Member Login

P: 404.221.0617

Fax: 404.448.3982

Email: admin@gabio.org

Address: 999 Peachtree Street NE #1800, Atlanta, GA 30309

State of Georgia Bio Virtual Town Hall: Wednesday, October 18 at 9:00 a.m.
Oct 11, 2023
Town Hall Meeting wordart

As many of our colleagues are now aware, the time has come for Georgia Bio (and the Georgia BioEd Institute) to separate from CGHI and adopt a more incremental, industry-focused approach to our efforts. Georgia Bio is recommitting to its core mission of advocating for, connecting, educating and inspiring our member enterprises and stakeholders in much the same way our colleagues have known Georgia Bio since its inception in 1989. We will now do that through an industry-wide lens more inclusive of new medical technologies and devices, and food and ag innovations.

We also know there are many related questions circling about.

On Wednesday, October 18 at 9:00 a.m. eastern we will host a virtual ‘town hall’ to discuss the state of Georgia Bio, Georgia BioEd and the larger life science ecosystem in the state. Georgia Bio CEO and team members will lead this discussion with ample room for Q&A. We invite you to register and join us

The 2023 Georgia Life Sciences Summit – November 1

We are also preparing the 2023 edition of the Georgia Bio Innovation Summit. The summit, more concentrated in scope yet expansive in industry inclusion, will be Wednesday, November 1st at the Sandy Springs Arts Center. The program is coming along nicely including a recently secured keynote or plenary address featuring Dr. Ted W. Love, former President and CEO of Global Blood Therapeutics and 2023-2025 Chair of the Board of the Biotechnology Innovation Organization (BIO).

We encourage you to join us in reconnecting with the life science industry ecosystem. Learn more and register here.

In the meantime, please know we are working diligently and with strong industry support to accomplish the following: rebuild trust with industry, strengthen brand awareness, simplify our message and respond to industry demand for a stronger unified voice on behalf of industry for policy priorities. As a 501c6, Georgia Bio can be more politically active and allows for future creation of a political action committee. (Of the 47 BIO/AdvaMed Affiliates all except two are 501c6 organizations.)

Biotechnology Innovation Organization (BIO) logo
By maria thacker 10 May, 2024
May 9, 2024 Source: BIO House lawmakers today unveiled a new draft of the BIOSECURE Act. Shortly after, BIO President and CEO, John F. Crowley, made the following statement: “The BIOSECURE bill released in the House today reinforces the national security imperative of the biotechnology industry as a critical strategic asset of the United States…
Capitol Building
By maria thacker 08 May, 2024
Contact Information: EPA Press Office (press@epa.gov) Source: https://www.epa.gov/newsreleases/epa-fda-and-usda-issues-updates-joint-regulatory-plan-biotechnology WASHINGTON – Today, May 8, 2024, in response to President Biden’s Executive Order 14081, “Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy,” the U.S. Environmental Protection Agency, the U.S. Food and Drug Administration and the U.S. Department of Agriculture have developed a plan to update, streamline…
Rdyus Research and Dt&CRO logo lockup
By maria thacker 07 May, 2024
Source: Radyus/PR Newswire ATLANTA, May 7, 2024 /PRNewswire/ — Radyus Research, a global drug development organization from Atlanta, Georgia, is excited to announce a pivotal strategic partnership with Dt&CRO, a leading South Korean contract research organization (CRO). This collaboration aims to assist South Korean biotech companies in entering the U.S. market by offering integrated services for drug development…
MORE POSTS
Share by: